Evaluation of programs for the treatment of benzodiazepine dependency.
Programs for the treatment of benzodiazepine dependency differ in a number of ways. Their outcome goals, for example, vary. In some of the programs the reduction or the elimination of benzodiazepine use is the main objective. In others a reduction in anxiety and depression among patients is regarded as much more important than decreasing benzodiazepine use. These differences in goals make comparative evaluations difficult. Further, the type of clients recruited to the programs are often dissimilar. However, it is still possible and valuable to make comparative evaluations of the numerous programs. The aims of published evaluations differ. Most evaluations are directed towards outcome data. Only in a few studies has the aim been to analyze the dynamic treatment process. To achieve more reliable and valid evaluations it is necessary to get data which describe the process and the results from both the clients' and the therapists' perspectives and combining different research strategies.
Lilja
J
J
Department of Biochemistry and Pharmacy, Abo Akademi, Turku, Finland. johnlilja@hotmail.com
Larsson
S
S
Skinhoj
K T
KT
Hamilton
D
D
D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D003365:Costs and Cost Analysis; D006801:Humans; D015397:Program Evaluation / Q000592:standards*; D019966:Substance-Related Disorders / Q000628:therapy*; D016896:Treatment Outcome
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines